| NCT03289910 |
Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia |
https://ClinicalTrials.gov/show/NCT03289910 |
Recruiting |
National Cancer Institute (NCI) |
2021-06-01 |
| NCT03246906 |
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation |
https://ClinicalTrials.gov/show/NCT03246906 |
Recruiting |
Fred Hutchinson Cancer Research Center |
2022-08-15 |
| NCT02861417 |
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT02861417 |
Recruiting |
M.D. Anderson Cancer Center |
2021-08-31 |
| NCT02727803 |
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple Myeloma |
https://ClinicalTrials.gov/show/NCT02727803 |
Recruiting |
M.D. Anderson Cancer Center |
2020-05-19 |
| NCT02666950 |
WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT02666950 |
Completed |
Mayo Clinic |
2018-09-25 |
| NCT02257138 |
Ruxolitinib Phosphate and Decitabine in Treating Patients With Relapsed or Refractory or Post Myeloproliferative Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02257138 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2021-02-28 |
| NCT02493530 |
TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea |
https://ClinicalTrials.gov/show/NCT02493530 |
Active, not recruiting |
Vanderbilt-Ingram Cancer Center |
2020-12-31 |
| NCT02210858 |
Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT02210858 |
Completed |
National Cancer Institute (NCI) |
2004-11-12 |
| NCT02158858 |
A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis |
https://ClinicalTrials.gov/show/NCT02158858 |
Recruiting |
Constellation Pharmaceuticals |
2021-08-31 |
| NCT02129101 |
Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies |
https://ClinicalTrials.gov/show/NCT02129101 |
Completed |
Mayo Clinic |
2016-12-31 |
| NCT01305200 |
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT01305200 |
Completed |
Children’s Oncology Group |
2015-06-30 |
| NCT01273766 |
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01273766 |
Completed |
Wake Forest University Health Sciences |
2012-03-31 |
| NCT01894477 |
Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01894477 |
Active, not recruiting |
Fred Hutchinson Cancer Research Center |
2017-01-09 |
| NCT01872819 |
Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay |
https://ClinicalTrials.gov/show/NCT01872819 |
Completed |
University of Washington |
2014-11-30 |
| NCT01831232 |
Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT01831232 |
Completed |
Fred Hutchinson Cancer Research Center |
2015-02-28 |
| NCT01789255 |
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT01789255 |
Completed |
National Cancer Institute (NCI) |
2014-03-31 |
| NCT01787487 |
Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm |
https://ClinicalTrials.gov/show/NCT01787487 |
Recruiting |
M.D. Anderson Cancer Center |
2020-07-26 |
| NCT01712308 |
Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia |
https://ClinicalTrials.gov/show/NCT01712308 |
Recruiting |
M.D. Anderson Cancer Center |
2020-02-28 |
| NCT01529827 |
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01529827 |
Completed |
Roswell Park Cancer Institute |
2015-05-28 |
| NCT01527045 |
Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT01527045 |
Completed |
Fred Hutchinson Cancer Research Center |
2018-10-31 |
| NCT01484015 |
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia |
https://ClinicalTrials.gov/show/NCT01484015 |
Completed |
Wake Forest University Health Sciences |
2012-06-30 |
| NCT01384513 |
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT01384513 |
Recruiting |
Thomas Jefferson University |
2020-12-31 |
| NCT03878524 |
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial |
https://ClinicalTrials.gov/show/NCT03878524 |
Recruiting |
OHSU Knight Cancer Institute |
2022-02-27 |
| NCT04282187 |
Decitabine With Ruxolitinib or Fedratinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms |
https://ClinicalTrials.gov/show/NCT04282187 |
Recruiting |
University of Washington |
2024-11-11 |
| NCT04022785 |
PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT04022785 |
Recruiting |
M.D. Anderson Cancer Center |
2022-12-31 |
| NCT03862157 |
Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT03862157 |
Recruiting |
M.D. Anderson Cancer Center |
2024-01-01 |
| NCT03630991 |
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy |
https://ClinicalTrials.gov/show/NCT03630991 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-12-31 |
| NCT03613532 |
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant for AML, MDS, and MDS/MPN |
https://ClinicalTrials.gov/show/NCT03613532 |
Recruiting |
Dana-Farber Cancer Institute |
2020-10-01 |
| NCT03560752 |
CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Blood Cancer Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03560752 |
Recruiting |
City of Hope Medical Center |
2021-03-18 |
| NCT03519984 |
EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia |
https://ClinicalTrials.gov/show/NCT03519984 |
Recruiting |
University of Southern California |
2020-05-09 |
| NCT03434730 |
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation |
https://ClinicalTrials.gov/show/NCT03434730 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-02-07 |
| NCT01233921 |
Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT01233921 |
Completed |
Fred Hutchinson Cancer Research Center |
2012-07-31 |
| NCT01164163 |
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease |
https://ClinicalTrials.gov/show/NCT01164163 |
Completed |
Children’s Oncology Group |
2014-10-31 |
| NCT01093586 |
Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01093586 |
Completed |
Case Comprehensive Cancer Center |
2015-12-31 |
| NCT01056614 |
Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies |
https://ClinicalTrials.gov/show/NCT01056614 |
Completed |
Fred Hutchinson Cancer Research Center |
2005-08-31 |
| NCT00988715 |
Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00988715 |
Completed |
Fred Hutchinson Cancer Research Center |
2015-01-31 |
| NCT00951626 |
A Standardized Nursing Intervention Protocol for HCT Patients |
https://ClinicalTrials.gov/show/NCT00951626 |
Completed |
City of Hope Medical Center |
2011-09-30 |
| NCT00935090 |
3’-Deoxy-3’-[18F] Fluorothymidine PET Imaging in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00935090 |
Recruiting |
Barbara Ann Karmanos Cancer Institute |
2021-04-30 |
| NCT00908167 |
Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT00908167 |
Completed |
St. Jude Children’s Research Hospital |
2015-06-30 |
| NCT00890747 |
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy |
https://ClinicalTrials.gov/show/NCT00890747 |
Completed |
National Cancer Institute (NCI) |
2011-05-31 |
| NCT00856388 |
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders |
https://ClinicalTrials.gov/show/NCT00856388 |
Completed |
Roswell Park Cancer Institute |
2012-08-09 |
| NCT00823524 |
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00823524 |
Completed |
Asan Medical Center |
2013-02-28 |
| NCT00806767 |
Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer |
https://ClinicalTrials.gov/show/NCT00806767 |
Completed |
National Cancer Institute (NCI) |
2011-05-31 |
| NCT00787761 |
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer |
https://ClinicalTrials.gov/show/NCT00787761 |
Completed |
Northside Hospital, Inc. |
2010-07-31 |
| NCT00782145 |
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families |
https://ClinicalTrials.gov/show/NCT00782145 |
Completed |
Tufts Medical Center |
2011-06-30 |
| NCT00755040 |
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder |
https://ClinicalTrials.gov/show/NCT00755040 |
Completed |
Vanderbilt-Ingram Cancer Center |
2014-12-31 |
| NCT00750009 |
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial |
https://ClinicalTrials.gov/show/NCT00750009 |
Completed |
Case Comprehensive Cancer Center |
2012-12-31 |
| NCT00719563 |
American Ginseng in Treating Patients With Fatigue Caused by Cancer |
https://ClinicalTrials.gov/show/NCT00719563 |
Completed |
Alliance for Clinical Trials in Oncology |
2011-08-31 |
| NCT00716911 |
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00716911 |
Completed |
City of Hope Medical Center |
2007-07-31 |
| NCT00691015 |
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00691015 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2014-04-30 |
| NCT00666211 |
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain |
https://ClinicalTrials.gov/show/NCT00666211 |
Completed |
Vanderbilt-Ingram Cancer Center |
2010-01-31 |
| NCT00627666 |
Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer |
https://ClinicalTrials.gov/show/NCT00627666 |
Completed |
National Cancer Institute (NCI) |
2010-06-30 |
| NCT00624936 |
Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00624936 |
Completed |
Ohio State University Comprehensive Cancer Center |
2009-12-31 |
| NCT00611351 |
Busulfan, Cyclophosphamide, and Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00611351 |
Completed |
University of Nebraska |
2008-02-29 |
| NCT00589563 |
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer |
https://ClinicalTrials.gov/show/NCT00589563 |
Completed |
City of Hope Medical Center |
2012-02-29 |
| NCT00588809 |
Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00588809 |
Completed |
National Cancer Institute (NCI) |
2012-04-30 |
| NCT00544115 |
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders |
https://ClinicalTrials.gov/show/NCT00544115 |
Active, not recruiting |
City of Hope Medical Center |
2019-11-30 |
| NCT00530218 |
Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant |
https://ClinicalTrials.gov/show/NCT00530218 |
Completed |
City of Hope Medical Center |
2010-02-28 |
| NCT00516503 |
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00516503 |
Completed |
Alliance for Clinical Trials in Oncology |
2009-04-30 |
| NCT00513474 |
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00513474 |
Completed |
Massachusetts General Hospital |
2013-02-12 |
| NCT00489203 |
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00489203 |
Completed |
Fred Hutchinson Cancer Research Center |
2010-11-30 |
| NCT00462605 |
MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT00462605 |
Completed |
National Cancer Institute (NCI) |
2011-03-31 |
| NCT00425477 |
Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00425477 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2016-09-30 |
| NCT00410657 |
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00410657 |
Completed |
Fred Hutchinson Cancer Research Center |
2006-11-30 |
| NCT00408681 |
Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00408681 |
Completed |
Fred Hutchinson Cancer Research Center |
2010-11-30 |
| NCT00799461 |
Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications |
https://ClinicalTrials.gov/show/NCT00799461 |
Completed |
Fred Hutchinson Cancer Research Center |
2011-11-30 |
| NCT00376922 |
Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases |
https://ClinicalTrials.gov/show/NCT00376922 |
Completed |
Wake Forest University Health Sciences |
2007-05-31 |
| NCT00357708 |
Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases |
https://ClinicalTrials.gov/show/NCT00357708 |
Completed |
National Cancer Institute (NCI) |
2009-10-31 |
| NCT00357305 |
Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00357305 |
Completed |
National Cancer Institute (NCI) |
2011-11-30 |
| NCT00351975 |
Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases |
https://ClinicalTrials.gov/show/NCT00351975 |
Completed |
National Cancer Institute (NCI) |
2013-03-31 |
| NCT00346359 |
Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer |
https://ClinicalTrials.gov/show/NCT00346359 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00331513 |
Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00331513 |
Completed |
National Cancer Institute (NCI) |
2010-01-31 |
| NCT00322101 |
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia |
https://ClinicalTrials.gov/show/NCT00322101 |
Completed |
Fred Hutchinson Cancer Research Center |
2012-04-30 |
| NCT00301938 |
7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00301938 |
Completed |
National Cancer Institute (NCI) |
2012-05-31 |
| NCT00293410 |
Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00293410 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2010-04-30 |
| NCT00293384 |
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00293384 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2009-06-30 |
| NCT00274820 |
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder |
https://ClinicalTrials.gov/show/NCT00274820 |
Completed |
Case Comprehensive Cancer Center |
2007-09-30 |
| NCT00265837 |
Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00265837 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2007-08-31 |
| NCT00255710 |
Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00255710 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
NA |
| NCT00245037 |
Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00245037 |
Completed |
OHSU Knight Cancer Institute |
2015-08-31 |
| NCT00217386 |
Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00217386 |
Completed |
Fred Hutchinson Cancer Research Center |
2007-12-31 |
| NCT00118352 |
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00118352 |
Completed |
Fred Hutchinson Cancer Research Center |
2010-07-31 |
| NCT00114257 |
Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00114257 |
Completed |
National Cancer Institute (NCI) |
2006-09-30 |
| NCT00112593 |
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer |
https://ClinicalTrials.gov/show/NCT00112593 |
Completed |
Fred Hutchinson Cancer Research Center |
2014-11-30 |
| NCT00109993 |
Campath-1H + FK506 and Methylprednisolone for GVHD |
https://ClinicalTrials.gov/show/NCT00109993 |
Completed |
Case Comprehensive Cancer Center |
2006-06-30 |
| NCT00105001 |
Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00105001 |
Completed |
Fred Hutchinson Cancer Research Center |
2011-05-31 |
| NCT00104975 |
Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00104975 |
Completed |
Yale University |
2008-05-31 |
| NCT00098683 |
Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00098683 |
Completed |
Children’s Oncology Group |
2007-10-31 |
| NCT00096161 |
Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00096161 |
Completed |
Fred Hutchinson Cancer Research Center |
2015-02-28 |
| NCT00096096 |
Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00096096 |
Completed |
Fred Hutchinson Cancer Research Center |
2006-05-31 |
| NCT00093366 |
Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00093366 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00089037 |
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00089037 |
Completed |
Fred Hutchinson Cancer Research Center |
2005-04-30 |
| NCT00006251 |
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer |
https://ClinicalTrials.gov/show/NCT00006251 |
Completed |
Fred Hutchinson Cancer Research Center |
2005-09-30 |
| NCT00082654 |
Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients |
https://ClinicalTrials.gov/show/NCT00082654 |
Completed |
Fred Hutchinson Cancer Research Center |
2004-10-31 |
| NCT00083187 |
VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia |
https://ClinicalTrials.gov/show/NCT00083187 |
Completed |
National Cancer Institute (NCI) |
2007-01-31 |
| NCT00080925 |
T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT00080925 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00078858 |
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00078858 |
Completed |
Fred Hutchinson Cancer Research Center |
2006-01-31 |
| NCT00077558 |
3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00077558 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
NA |
| NCT00075816 |
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) |
https://ClinicalTrials.gov/show/NCT00075816 |
Completed |
Medical College of Wisconsin |
2013-04-30 |
| NCT00075478 |
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00075478 |
Completed |
Fred Hutchinson Cancer Research Center |
2014-02-28 |
| NCT00072475 |
Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00072475 |
Completed |
Alliance for Clinical Trials in Oncology |
2008-11-30 |
| NCT00068523 |
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT00068523 |
Completed |
Case Comprehensive Cancer Center |
2004-03-31 |
| NCT00068276 |
Cholecalciferol in Treating Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00068276 |
Completed |
Wake Forest University Health Sciences |
2005-06-30 |
| NCT00066599 |
Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy |
https://ClinicalTrials.gov/show/NCT00066599 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00066248 |
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment |
https://ClinicalTrials.gov/show/NCT00066248 |
Completed |
University of South Florida |
2007-08-31 |
| NCT00064311 |
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00064311 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00003913 |
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease |
https://ClinicalTrials.gov/show/NCT00003913 |
Completed |
Fred Hutchinson Cancer Research Center |
2005-08-31 |
| NCT00064090 |
3-AP and Cytarabine in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00064090 |
Completed |
National Cancer Institute (NCI) |
2004-09-30 |
| NCT00062140 |
Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00062140 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00006225 |
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00006225 |
Completed |
Northwestern University |
2004-01-31 |
| NCT00055653 |
Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00055653 |
Completed |
Roswell Park Cancer Institute |
2003-09-30 |
| NCT00054340 |
Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder |
https://ClinicalTrials.gov/show/NCT00054340 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00054327 |
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00054327 |
Completed |
Case Comprehensive Cancer Center |
2011-09-30 |
| NCT00054236 |
Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00054236 |
Completed |
Case Comprehensive Cancer Center |
2011-03-31 |
| NCT00053989 |
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders |
https://ClinicalTrials.gov/show/NCT00053989 |
Completed |
Roswell Park Cancer Institute |
2018-07-19 |
| NCT00053287 |
Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS |
https://ClinicalTrials.gov/show/NCT00053287 |
Completed |
Case Comprehensive Cancer Center |
2007-01-31 |
| NCT00053157 |
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00053157 |
Completed |
Roswell Park Cancer Institute |
2004-08-31 |
| NCT00053001 |
Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00053001 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00052832 |
Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia |
https://ClinicalTrials.gov/show/NCT00052832 |
Completed |
University of Wisconsin, Madison |
2005-07-31 |
| NCT00049686 |
VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00049686 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00049634 |
Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder |
https://ClinicalTrials.gov/show/NCT00049634 |
Completed |
Fred Hutchinson Cancer Research Center |
2007-02-28 |
| NCT00045305 |
Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00045305 |
Completed |
Eastern Cooperative Oncology Group |
2014-02-28 |
| NCT00044954 |
Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00044954 |
Completed |
University of Texas Southwestern Medical Center |
2006-11-30 |
| NCT00042822 |
FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00042822 |
Completed |
National Cancer Institute (NCI) |
2005-03-31 |
| NCT00040846 |
Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT00040846 |
Completed |
Fred Hutchinson Cancer Research Center |
2009-12-31 |
| NCT00036790 |
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00036790 |
Completed |
University of Wisconsin, Madison |
2005-10-31 |
| NCT00030550 |
Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00030550 |
Completed |
Roswell Park Cancer Institute |
2003-06-30 |
| NCT00028730 |
Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00028730 |
Completed |
Memorial Sloan Kettering Cancer Center |
2006-07-31 |
| NCT00027560 |
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00027560 |
Completed |
Memorial Sloan Kettering Cancer Center |
2009-04-30 |
| NCT00025415 |
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction |
https://ClinicalTrials.gov/show/NCT00025415 |
Completed |
National Cancer Institute (NCI) |
2005-01-31 |
| NCT00022048 |
Bevacizumab in Treating Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00022048 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00019656 |
Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00019656 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00015925 |
MS-275 in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00015925 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
NA |
| NCT00014495 |
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer |
https://ClinicalTrials.gov/show/NCT00014495 |
Completed |
Memorial Sloan Kettering Cancer Center |
2009-12-31 |
| NCT00014469 |
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00014469 |
Completed |
Memorial Sloan Kettering Cancer Center |
2007-05-31 |
| NCT00795769 |
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00795769 |
Completed |
Fred Hutchinson Cancer Research Center |
2009-06-09 |
| NCT00014235 |
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT00014235 |
Completed |
Fred Hutchinson Cancer Research Center |
2005-02-28 |
| NCT00006379 |
Non-Ablative Allo HSCT For Hematologic Malignancies or SAA |
https://ClinicalTrials.gov/show/NCT00006379 |
Completed |
Case Comprehensive Cancer Center |
2004-01-31 |
| NCT00006239 |
Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00006239 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-02-28 |
| NCT00006042 |
Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00006042 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
NA |
| NCT00006040 |
Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia |
https://ClinicalTrials.gov/show/NCT00006040 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-11-30 |
| NCT00005863 |
Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00005863 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00005823 |
Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00005823 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00005797 |
Bone Marrow Transplant in Treating Patients With Hematologic Cancers |
https://ClinicalTrials.gov/show/NCT00005797 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2007-07-31 |
| NCT00005622 |
Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00005622 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2005-09-30 |
| NCT00004899 |
Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00004899 |
Completed |
Northwestern University |
2004-08-31 |
| NCT00004896 |
Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00004896 |
Completed |
Northwestern University |
2004-08-31 |
| NCT00004871 |
Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00004871 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
NA |
| NCT00004245 |
Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT00004245 |
Completed |
Memorial Sloan Kettering Cancer Center |
2004-09-30 |
| NCT00003961 |
Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00003961 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2007-12-31 |
| NCT00003816 |
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00003816 |
Completed |
Roswell Park Cancer Institute |
2019-07-12 |
| NCT00003593 |
Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00003593 |
Completed |
Children’s Oncology Group |
2007-03-31 |
| NCT00003336 |
Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions |
https://ClinicalTrials.gov/show/NCT00003336 |
Completed |
Case Comprehensive Cancer Center |
2005-12-31 |
| NCT00003335 |
Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00003335 |
Completed |
Case Comprehensive Cancer Center |
2007-11-30 |
| NCT00003243 |
Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00003243 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
NA |
| NCT00003116 |
High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00003116 |
Completed |
Case Comprehensive Cancer Center |
2006-03-31 |
| NCT00002809 |
Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00002809 |
Completed |
Temple University |
2003-12-31 |
| NCT00002792 |
Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00002792 |
Completed |
Fred Hutchinson Cancer Research Center |
2003-04-30 |
| NCT00002746 |
Interleukin-2 in Treating Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00002746 |
Completed |
University of Washington |
2004-04-30 |
| NCT00002718 |
T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00002718 |
Completed |
Memorial Sloan Kettering Cancer Center |
2004-01-31 |